The Functionality of p53 in Thyroid Cancer

Part of book or chapter of book English OPEN
Ray, Debolina; Balmer, Matthew T.; Gal, Susannah;
  • Publisher: InTech
  • References (76)
    76 references, page 1 of 8

    Alarcon-Vargas, D. & Ronai, Z. (2002). p53-Mdm2--the affair that never ends. Carcinogenesis, Vol. 23, pp. 541-547.

    Alsner, J.; Jensen, V.; Kyndi, M.; Offersen, B.V.; Vu, P.; Børresen-Dale, A.L. & Overgaard J. (2008). A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients. Acta Oncologica, Vol. 47, pp. 600-607.

    Appella, E. & Anderson, C.W. (2000). Signaling to p53: breaking the posttranslational modification code. Pathological Biology,Vol. 48, pp 227-245.

    Bai, L. & Zhu, W.G. (2006). P53: Structure, function and therapeutic applications. Journal of Cancer Molecules, Vol. 2, pp. 141-153.

    Bell, D.; Varley, J.M.; Szydlo, T.E.; Kang, D.H.; Wahrer, D.C.R.; Shannon, K.E.; Lubratovich, M.; Verselis, S.J.; Isselbacher, K.J.; Fraumeni, J.F.; Birch, J.M.; Li, F.P.; Garber, J.E. & Haber, D.A. ( 1999). Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science, Vol. 286, pp. 2528-2531.

    Blagosklonny, M.V.; Giannakakou, P.; Wojtowicz, M.; Romanova, L.Y.; Ain, K.B.; Bates, S.E. & Fojo, T. (1998). Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic thyroid cancer cells. Journal of Clinical Endocrinology and Metabolism, Vol. 83, pp. 2516-22.

    Chan, W.M.; Siu, W.Y.; Lau, A. & Poon, R.Y. (2004). How many mutant p53 molecules are needed to inactivate a tetramer? Molecular and Cell Biology, Vol.24, pp. 3536-3551.

    Chandrachud, U. & Gal, S. (2009). Three assays show differences in binding of wild-type and mutant p53 to unique gene sequences. Technology in Cancer Research and Treatment, Vol. 8, pp. 445-454.

    Chuang, Y.Y.E.; Chen, Y.; Chandramouli, GVR.; Cook, JA.; Coffin, D.; Tsai, MH.; DeGraff, W.; Yan H.; Zhao, S.; Russo, A.; Liu, ET. & Mitchell, J.B. (2002). Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Research. Vol. 62, pp. 6246 - 6254.

    Collavin, L.; Lunardi, A. & Sal, G. D. (2010). p53-family proteins and their regulators: hubs and spokes in tumor suppression. Cell Death and Differentiation, Vol. 17, pp. 901-911.

  • Metrics
Share - Bookmark

  • Download from
    InTech via InTech (Part of book or chapter of book, 2012)
  • Cite this publication